Table 6.
n (%) | ARDS |
Mortality |
||||
---|---|---|---|---|---|---|
OR | CI 95% | p value | OR | CI 95% | p value | |
Age, >65 years | 1.17 | 0.42–3.2 | 0.76 | 1.59 | 0.5–4.99 | 0.42 |
Sex, Female = 1 | 0.98 | 0.35–2.74 | 0.98 | 0.88 | 0.28–2.73 | 0.83 |
Smoking habit | ||||||
Former smoker | 0.81 | 0.27–2.45 | 0.72 | 0.89 | 0.25–3.11 | 0.86 |
Current smoker | 2.4 | 0.48–11.8 | 0.28 | 2.48 | 0.5–12.54 | 0.27 |
Comorbidities | ||||||
Hypertensiona | 1.5 | 0.5–4.43 | 0.46 | 2 | 0.68–5.88 | 0.21 |
Diabetesa | 2.4 | 0.63–9.44 | 0.19 | 1.15 | 0.34–3.9 | 0.81 |
CKDa | 3.5 | 0.46–26.18 | 0.22 | 2.39 | 0.29–19.85 | 0.42 |
COPDa | 0.79 | 0.18–3.34 | 0.75 | 0.35 | 0.05–2.23 | 0.26 |
Previous VTEDa | 1.79 | 0.48–6.7 | 0.39 | 4.82 | 1.14–20.3 | 0.03 |
Chronic anaemiac | 2.76 | 0.62–12.3 | 0.18 | 1.32 | ||
ACEI/ARBsIb | 0.64 | 0.11–3.5 | 0.6 | 0.23 | 0.02–2.23 | 0.2 |
COPDd | 1.69 | 0.33–8.62 | 0.52 | 1.43 | 0.25–8.33 | 0.68 |
Radiol infiltrates bilateral=1 | 21.4 | 4.2–108.55 | <0.001 | 32.83 | 3.51–307 | 0.002 |
Neutropeniae | ||||||
<1500 | 0.46 | 0.13–1.58 | 0.21 | 0.62 | 0.16–2.37 | 0.43 |
<500 | 10.36 | 0.93–114.52 | 0.056 | 16.54 | 1.43–190.9 | 0.025 |
Primary tumourf | ||||||
Overall lung cancer | 1.81 | 0.49–6.7 | 0.37 | 2.35 | 0.58–9.51 | 0.22 |
Colorectal cancer (lung=1) | 1.65 | 0.1–16.97 | 0.81 | 2.33 | 0.17–30.94 | 0.52 |
Breast cancer (lung=1) | 0.9 | 0.12–6.54 | 0.9 | 2.47 | 0.17–34.23 | 0.5 |
Genitourinary cancer (lung=1) | 1.56 | 0.17–14.13 | 0.69 | 2.29 | 0.17–30.73 | 0.53 |
Other tumours (lung=1) | 1.86 | 0.37–9.19 | 0.44 | 2.13 | 0.42–10.82 | 0.36 |
Metastatic diseaseg | 1.11 | 0.23–5.38 | 0.88 | 1.88 | 0.19–18.19 | 0.58 |
Visceral metastatasish | 0.7 | 0.21–2.25 | 0.54 | 1.32 | 0.38–4.55 | 0.44 |
Pulmonary involvementi | 1.96 | 0.63–6.14 | 0.24 | 4.34 | 1.26–14.95 | 0.02 |
Cancer Treamentj | ||||||
Chemotherapy alone | 1.36 | 0.4-4-56 | 0.68 | 1.6 | 0.4–6.33 | 0.5 |
Immunotherapy + Chemo | 0.97 | 0.14–6.45 | 0.95 | 1,96 | 0.29–13.18 | 0.49 |
Immnunotherapy alone | 0.26 | 0.03–1.88 | 0.18 | 0.15 | 0.01–1.65 | 0.12 |
CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; VTED, venous thromboembolic disease; ACEi/ARBs, angiotensin converting enzyme inhibitor/angiotensin receptor blockers; ECOG, Eastern Cooperative Oncology Group; OR, odds ratio; CI, confidence interval.
Adjusted by age, sex, hypertension, diabetes, CKD, COPD, previous VTE, smoking habit.
Adjusted by age, sex, hypertension, diabetes, CKD, COPD, smoking habit.
Adjusted by age, sex, hypertension, diabetes, CKD, COPD, Previous VTE, smoking habit, oesophagogastric tumour.
Adjusted by age, sex, cardiopathy, previous VTED.
Adjusted by age, sex, hypertension, diabetes, CKD, COPD, Previous VTE, smoking habit.
Adjusted by age, sex, CT.
Adjusted by age, sex, COPD, previous VTE, metastasis, ECOG.
Adjusted by age, sex, previous VTE, pulmonary involvement.
Adjusted by age, sex, ECOG, metastasis, previous VTE.
Adjusted by age, sex, ECOG, metastasis, previous VTE, COPD.